Mechanisms of Desmosome Regulation and Disassembly in the Skin Disease Pemphigus
皮肤病天疱疮中桥粒调节和分解的机制
基本信息
- 批准号:7482134
- 负责人:
- 金额:$ 38.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-08-01 至 2008-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsAdhesivesAmino AcidsAntibodiesAutoantibodiesAutoimmune ProcessBiologyBullaCadherinsCell Adhesion MoleculesCell surfaceCell-Cell AdhesionCellsCharacteristicsClassComplementComplexCouplesCultured CellsCytokeratin filamentsCytoplasmic TailCytoskeletal ModelingDesmosomesDiseaseDisruptionEndocytosisExposure toFunctional disorderFundingGoalsImmunoglobulin GIn VitroInborn Genetic DiseasesIndividualIntercellular JunctionsIntermediate FilamentsKeratinLaboratoriesLeadLifeMediatingMembrane Protein TrafficMicroscopyModelingMolecularMucous MembraneMusPathogenicityPathway interactionsPatientsPemphigusPemphigus VulgarisPhasePlayProcessProteinsReagentRegulationResearch DesignRoleSeriesSignal PathwaySkinStructureTailTestingTherapeuticThinkingWorkarmadillo proteinsbasedesmoglein IIIdesmoplakinhuman monoclonal antibodiesin vivoin vivo Modelinsightkeratinocytemembernovel therapeuticsplakophilinspolypeptide D6preventresponseskin disordertherapeutic target
项目摘要
Pemphigus is a class of devastating epidermal blistering diseases in which autoantibodies are generated
against cell-cell adhesion molecules present in the skin and mucous membranes. Pemhigus IgG target
desmosomes, a structure that couples the keratin intermediate filament network to regions of strong cell-cell
adhesion. In pemphigus vulgaris (PV), the primary target of the autoantibodies is desmoglein-3 (Dsg3), a
member of the desmosomal cadherin subfamily of adhesion molecules. The work outlined in this proposal
investigates the mechanisms by which IgG from pemphigus vulgaris patients disrupts cell-cell adhesion. It is
hypothesized that PV IgG disrupt desmosomes by causing Dsg3 internalization from the cell surface, leading
to desmosome destabilization and loss of keratinocyte adhesion. This hypothesis will be tested using a
series of in vitro cell culture models that employ cellular and molecular approaches to define the
mechanisms by which PV IgG cause Dsg3 internalization and desmosome disassembly. These studies will
reveal the cellular machinery and pathways that mediate Dsg3 endocytosis, and how cytoplasmic
components of the desmosome regulate Dsg3 internalization. These studies will be complemented by in
vivo models of disease to determine if agents that block PV IgG induced loss of adhesion in vitro can also
block loss of adhesion in vivo. A panel of antibody reagents will be employed, including PV patient IgG,
human monoclonal antibodies isolated from patients, and mouse monoclonal Dsg3 antibodies with varying
degrees of pathogenic activity. These reagents will be used to reveal relationships between desmosome
disassembly pathways and antibody pathogenicity profiles to determine how pemphigus IgG cause disease
at the cellular level. These studies are designed to generate new insights into the basic cellular mechanisms
that regulate cell-cell adhesion, and to expose new therapeutic targets for the treatment of pemphigus and
other skin diseases characterized by epidermal fragility.
天疱疮是一类破坏性的表皮起泡疾病,其中产生自身抗体
对抗皮肤和粘膜中存在的细胞-细胞粘附分子。天疱疮IgG靶标
桥粒,一种将角蛋白中间丝网络与强细胞间连接区域偶联的结构。
粘连在寻常型天疱疮(PV)中,自身抗体的主要靶点是桥粒芯糖蛋白-3(Dsg 3),
粘附分子桥粒钙粘蛋白亚家族成员。本提案中概述的工作
研究寻常天疱疮患者IgG破坏细胞间粘附的机制。是
假设PV IgG通过引起Dsg 3从细胞表面内化而破坏桥粒,
导致桥粒不稳定和角质形成细胞粘附丧失。这个假设将使用一个
一系列体外细胞培养模型,采用细胞和分子方法来定义
PV IgG引起Dsg 3内化和桥粒解体的机制。这些研究将
揭示了介导Dsg 3内吞作用的细胞机制和途径,以及细胞质如何
桥粒的组分调节Dsg 3内化。这些研究将得到补充,
体内疾病模型,以确定在体外阻断PV IgG诱导的粘附丧失的药物是否也可以
阻断体内粘连丧失。将使用一组抗体试剂,包括PV患者IgG,
从患者分离的人单克隆抗体,和具有不同
致病活动的程度。这些试剂将用于揭示桥粒之间的关系
拆卸途径和抗体致病性谱,以确定天疱疮IgG如何引起疾病
在细胞水平上。这些研究旨在对基本的细胞机制产生新的见解
调节细胞-细胞粘附,并揭示用于治疗天疱疮的新治疗靶点,
其他以表皮脆弱为特征的皮肤病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW P. KOWALCZYK其他文献
ANDREW P. KOWALCZYK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW P. KOWALCZYK', 18)}}的其他基金
Keratinocyte adhesion and signaling in the skin blistering disease pemphigus vulgaris
皮肤起疱病寻常型天疱疮中的角质形成细胞粘附和信号传导
- 批准号:
10732360 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Cadherin regulation in dermal endothelial cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
8526381 - 财政年份:2004
- 资助金额:
$ 38.25万 - 项目类别:
Cadherin Regulation in Dermal Endothelial Cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
9381479 - 财政年份:2004
- 资助金额:
$ 38.25万 - 项目类别:
Cadherin Regulation in Dermal Endothelial Cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
7227094 - 财政年份:2004
- 资助金额:
$ 38.25万 - 项目类别:
Cadherin Regulation in Dermal Endothelial Cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
6929228 - 财政年份:2004
- 资助金额:
$ 38.25万 - 项目类别:
Cadherin Regulation in Dermal Endothelial Cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
6820500 - 财政年份:2004
- 资助金额:
$ 38.25万 - 项目类别:
Cadherin Regulation in Dermal Endothelial Cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
9982790 - 财政年份:2004
- 资助金额:
$ 38.25万 - 项目类别:
Cadherin Regulation in Dermal Endothelial Cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
9752474 - 财政年份:2004
- 资助金额:
$ 38.25万 - 项目类别:
Cadherin regulation in dermal endothelial cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
7727763 - 财政年份:2004
- 资助金额:
$ 38.25万 - 项目类别:
Cadherin regulation in dermal endothelial cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
8185601 - 财政年份:2004
- 资助金额:
$ 38.25万 - 项目类别:
相似海外基金
I-Corps: Translation Potential of Peptidic Ensembles as Novel Bio-adhesives
I-Corps:肽整体作为新型生物粘合剂的转化潜力
- 批准号:
2409620 - 财政年份:2024
- 资助金额:
$ 38.25万 - 项目类别:
Standard Grant
Architectural design of active adhesives
活性粘合剂的结构设计
- 批准号:
2403716 - 财政年份:2024
- 资助金额:
$ 38.25万 - 项目类别:
Standard Grant
Design of non-swellable adhesives for brain surgery using cyclodextrin inclusion polymer
使用环糊精包合物聚合物脑外科不可溶胀粘合剂的设计
- 批准号:
23H01718 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Meta-material adhesives for improved performance and functionalisation of bondlines
超材料粘合剂可提高粘合层的性能和功能化
- 批准号:
EP/W019450/1 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Fellowship
Light-propelled dental adhesives with enhanced bonding capability
具有增强粘合能力的光驱动牙科粘合剂
- 批准号:
10741660 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
DMREF: Accelerating the Design of Adhesives with Nanoscale Control of Thermomechanical Properties
DMREF:通过热机械性能的纳米级控制加速粘合剂的设计
- 批准号:
2323317 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Continuing Grant
Mag-Cure: A novel method for magnetically induced bonding and de-bonding of thermoset adhesives in the Automotive Industry
Mag-Cure:汽车行业中热固性粘合剂磁感应粘合和脱粘的新方法
- 批准号:
10062336 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Collaborative R&D
Biodegradable, Biocompatible Pressure Sensitive Adhesives
可生物降解、生物相容性压敏粘合剂
- 批准号:
10677869 - 财政年份:2022
- 资助金额:
$ 38.25万 - 项目类别:
Poly(glycerol carbonate) pressure sensitive adhesives for the in vivo closure of alveolar pleural fistulae
用于体内闭合肺泡胸膜瘘的聚(甘油碳酸酯)压敏粘合剂
- 批准号:
10746743 - 财政年份:2022
- 资助金额:
$ 38.25万 - 项目类别:
Enhanced bio-production of difficult to make peptide ingredients for specialty adhesives and personal care
增强用于特种粘合剂和个人护理品的难以制造的肽成分的生物生产
- 批准号:
10021363 - 财政年份:2022
- 资助金额:
$ 38.25万 - 项目类别:
Investment Accelerator